RVPH
Price:
$2.8
Market Cap:
$93.64M
Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP5063, which is in Phase III clinical trials for the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity di...[Read more]
Industry
Biotechnology
IPO Date
2018-10-18
Stock Exchange
NASDAQ
Ticker
RVPH
According to Reviva Pharmaceuticals Holdings, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 88.16M. This represents a change of 152.60% compared to the average of 34.90M of the last 4 quarters.
The mean historical Enterprise Value of Reviva Pharmaceuticals Holdings, Inc. over the last ten years is 37.95M. The current 88.16M Enterprise Value has changed 23.13% with respect to the historical average. Over the past ten years (40 quarters), RVPH's Enterprise Value was at its highest in in the February 2019 quarter at 182.90M. The Enterprise Value was at its lowest in in the December 2023 quarter at -23367456.00.
Average
37.95M
Median
25.51M
Minimum
0
Maximum
99.19M
Discovering the peaks and valleys of Reviva Pharmaceuticals Holdings, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual Enterprise Value = 99.19M
Minimum Annual Increase = -45.50%
Minimum Annual Enterprise Value = 0
Year | Enterprise Value | Change |
---|---|---|
2023 | 99.19M | 53.97% |
2022 | 64.43M | 393.39% |
2021 | 13.06M | -27.45% |
2020 | 18.00M | -45.50% |
2020 | 33.02M | Infinity% |
The current Enterprise Value of Reviva Pharmaceuticals Holdings, Inc. (RVPH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
58.89M
5-year avg
45.54M
10-year avg
37.95M
Reviva Pharmaceuticals Holdings, Inc.’s Enterprise Value is less than Ocuphire Pharma, Inc. (0), greater than Protalix BioTherapeutics, Inc. (-9671816.00), less than EyePoint Pharmaceuticals, Inc. (110.82M), less than SELLAS Life Sciences Group, Inc. (488.78M), greater than IN8bio, Inc. (41.69M), greater than Cue Biopharma, Inc. (24.46M), greater than Lantern Pharma Inc. (43.93M), greater than Gracell Biotechnologies Inc. (32.42M), less than Sigilon Therapeutics, Inc. (5.63B), greater than ZyVersa Therapeutics, Inc. (42.21M), greater than Kiromic BioPharma, Inc. (2.50M), greater than Unicycive Therapeutics, Inc. (13.26M), greater than Athira Pharma, Inc. (50.47M), greater than Fortress Biotech, Inc. (-44089191.00), greater than ACADIA Pharmaceuticals Inc. (69.68M), less than Cabaletta Bio, Inc. (2.84B), greater than null (-4842224.00),
Company | Enterprise Value | Market cap |
---|---|---|
0 | $31.74M | |
-9671816.00 | $132.54M | |
110.82M | $546.69M | |
488.78M | $62.15M | |
41.69M | $22.99M | |
24.46M | $66.83M | |
43.93M | $40.23M | |
32.42M | $989.87M | |
5.63B | $56.22M | |
42.21M | $2.62M | |
2.50M | $1.47M | |
13.26M | $82.01M | |
50.47M | $23.45M | |
-44089191.00 | $57.00M | |
69.68M | $2.95B | |
2.84B | $150.54M | |
-4842224.00 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Reviva Pharmaceuticals Holdings, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Reviva Pharmaceuticals Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Reviva Pharmaceuticals Holdings, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Reviva Pharmaceuticals Holdings, Inc. (RVPH)?
What is the 3-year average Enterprise Value for Reviva Pharmaceuticals Holdings, Inc. (RVPH)?
What is the 5-year average Enterprise Value for Reviva Pharmaceuticals Holdings, Inc. (RVPH)?
How does the current Enterprise Value for Reviva Pharmaceuticals Holdings, Inc. (RVPH) compare to its historical average?